These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. ME1. A monoclonal antibody that distinguishes epithelial-type malignant mesothelioma from pulmonary adenocarcinoma and extrapulmonary malignancies. O'Hara CJ, Corson JM, Pinkus GS, Stahel RA. Am J Pathol; 1990 Feb; 136(2):421-8. PubMed ID: 2305835 [Abstract] [Full Text] [Related]
6. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions. Bassarova AV, Nesland JM, Davidson B. Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331 [Abstract] [Full Text] [Related]
9. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions. Shield PW, Koivurinne K. Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095 [Abstract] [Full Text] [Related]
10. The diagnostic role of claudins in serous effusions. Kleinberg L, Holth A, Fridman E, Schwartz I, Shih IeM, Davidson B. Am J Clin Pathol; 2007 Jun; 127(6):928-37. PubMed ID: 17509990 [Abstract] [Full Text] [Related]
11. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion]. Su XY, Li GD, Liu HB, Jiang LL. Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932 [Abstract] [Full Text] [Related]
13. The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis. Cury PM, Butcher DN, Corrin B, Nicholson AG. J Pathol; 1999 Oct; 189(2):251-7. PubMed ID: 10547583 [Abstract] [Full Text] [Related]
14. Identification of carcinoma cells in ascitic and pleural fluid. Comparison of four panepithelial antigens with carcinoembryonic antigen. Mezger J, Stötzer O, Schilli G, Bauer S, Wilmanns W. Acta Cytol; 1992 Oct; 36(1):75-81. PubMed ID: 1546516 [Abstract] [Full Text] [Related]
15. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions. Zhu W, Michael CW. Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661 [Abstract] [Full Text] [Related]
16. Monoclonal antibody MOC-31 reactivity as a marker for adenocarcinoma in cytologic preparations. Hecht JL, Pinkus JL, Pinkus GS. Cancer; 2006 Feb 25; 108(1):56-9. PubMed ID: 16329115 [Abstract] [Full Text] [Related]
17. Podoplanin is a useful marker for identifying mesothelioma in malignant effusions. Hanna A, Pang Y, Bedrossian CW, Dejmek A, Michael CW. Diagn Cytopathol; 2010 Apr 25; 38(4):264-9. PubMed ID: 20146302 [Abstract] [Full Text] [Related]
18. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions. Davidson B, Berner A, Nesland JM, Risberg B, Kristensen GB, Tropé CG, Bryne M. Hum Pathol; 2000 Sep 25; 31(9):1081-7. PubMed ID: 11014575 [Abstract] [Full Text] [Related]
19. Expression of epithelial membrane antigen on malignant mesothelioma cells. An immunocytochemical and immunoelectron microscopic study. van der Kwast TH, Versnel MA, Delahaye M, de Jong A, Zondervan PE, Hoogsteden H. Acta Cytol; 1988 Sep 25; 32(2):169-74. PubMed ID: 3348058 [Abstract] [Full Text] [Related]
20. Differential diagnosis between mesotheliomas and metastatic adenocarcinomas using monoclonal antibodies against gastrointestinal carcinoma antigen and stage-specific embryonic antigen. Ernst CS, Atkinson B, Chianese D, Peters J, Perry M, Herlyn M, Koprowski H. Appl Pathol; 1986 Sep 25; 4(3):115-24. PubMed ID: 2885017 [Abstract] [Full Text] [Related] Page: [Next] [New Search]